
Breast Cancer receptor 2-positive and First-Line Regimens With Endocrine Therapy Show Benefits
ERBB2-positive metastatic breast cancer benefits from endocrine therapy. Explore personalized regimens for improved patient outcomes. Read more on potential clinical implications.










